HOMA2-IR

Biomarker

2 papers2 findings

  • Humans2

Associations

2

Hepatocellular carcinoma

upin humans1HR 1.53

1 study
  1. HOMA2-IR predicts hepatocellular carcinoma in humans (Adjusted HR 1.53 per unit increase, 95% CI 1.16–2.04).

    HumansHBV-related cirrhosis with virological response to nucleos(t)ide analogue therapy; per unit increase in baseline HOMA2-IRMedian follow-up 7.45 yearsn = 334

    Insulin Resistance and Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients Under Antiviral Therapy

    Journal of Korean medical science5 Oct 2026

More on Hepatocellular carcinoma

Heart failure

upin humans1HR 1.89

1 study
  1. HOMA2-IR raises the risk of heart failure in humans (HR 1.89, 95% CI 1.02–3.48).

    Humansin low-risk individuals with newly diagnosed diabetes

    Incidence and independent risk factors for heart failure in a population-based cohort of 19,892 individuals with newly diagnosed diabetes

    Diabetologia3 Aug 2026

More on Heart failure

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 3Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 16 in 12 months